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Edited by Barry HalliwellAbstract Reactive oxygen and nitrogen species (ROS and
RNS) have been proposed as mechanisms of cancer-induced ca-
chexia. In this study, we assessed using Western blot analysis the
levels of total protein carbonylation (2,4-dinitrophenylhydrazine
assay), both malondialdehyde- (MDA-) and 2-hydroxy-4-none-
nal- (HNE-) protein adducts, Mn-superoxide dismutase (Mn-
SOD), catalase, heme oxygenase-1 (HO-1) and 3-nitrotyrosine
formation in gastrocnemius muscles of rats bearing the Yoshida
AH-130 hepatoma. In the muscles of the tumour-bearing ani-
mals, protein carbonylation as measured by total levels of car-
bonyl group formation and both HNE and MDA-protein
adducts, and protein tyrosine nitration were signiﬁcantly greater
than in control muscles. Protein levels of the antioxidant en-
zymes Mn-SOD, catalase, and HO-1 were not signiﬁcantly
modiﬁed in the rat cachectic muscles compared to controls.
The ineﬃciency of the antioxidant enzymes in neutralizing
excessive ROS production may account for elevated markers
of protein oxidation and be responsible for the development of
both oxidative and nitrosative stress in cancer-induced cachexia.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Oxidative stress; Nitrosative stress; Skeletal muscle;
Cachexia1. Introduction
The development of cancer cachexia is the most common
manifestation of advanced malignant disease. Indeed, ca-
chexia occurs in the majority of cancer patients before
death, and it is responsible for the death of 22% of cancer
patients [1]. The abnormalities associated with cancer ca-
chexia include anorexia, weight loss, muscle loss and atro-
phy, anemia and alterations in carbohydrate, lipid, and
protein metabolism [2]. The degree of cachexia is inversely
correlated with the survival time of the patient and it always
implies a poor prognosis [3–5]. Asthenia (lack of muscular
strength), which reﬂects the important muscle waste that
takes place in the cachectic cancer patient, is one of the
most relevant characteristics of cachexia [6]. Asthenia is also*Corresponding author. Fax: +34 934021559.
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mental fatigue [7]. In addition, lean body mass depletion is
one of the main trends of cachexia and it involves not only
skeletal muscle but it also aﬀects cardiac proteins, resulting
in important alterations in heart performance.
The rat ascites hepatoma Yoshida AH-130 is a suitable
model system to study the mechanisms involved in the
establishment of cachexia. Its growth causes rapid and pro-
gressive loss of body weight and tissue waste, particularly in
skeletal muscle [8]. Acceleration of tissue protein breakdown
accounts for most of the waste in the AH-130 bearers [9–11];
in particular, skeletal muscle hypercatabolism is mainly due
to hyperactivation of the ATP–ubiquitin-dependent proteo-
lytic system [12]. High plasma levels of tumour necrosis fac-
tor-a (TNF) [13] and perturbations in the hormonal
homeostasis [14] may play an important role in forcing the
metabolic balance towards the catabolic side. In addition
to increased muscle protein degradation during cancer
growth, the presence of the tumour also induces an in-
creased rate of apoptosis in skeletal muscle in rats [15],
which also seems to be activated by cytokines, TNF in par-
ticular [16].
Oxidative stress due to greater levels of reactive oxygen
species (ROS) production than those normally neutralized
by intracellular antioxidant defenses has recently gained
much attention for its possible involvement in cancer ca-
chexia. Buck and Chojkier [17] demonstrated that muscle
wasting and dediﬀerentiation could be prevented by inhibi-
tors of nitric oxide (NO) synthesis and antioxidants. Simi-
larly, Gomes-Marcondes and Tisdale [18] have shown that
muscle wasting in cancer cachexia is associated with in-
creased levels of malondialdehyde in gastrocnemius muscles,
and that mild oxidative stress increased protein degradation
in skeletal muscle by causing a greater expression of the ma-
jor components of the ubiquitin–proteasome pathway. In
addition, Murr et al. [19] have shown elevated neopterin
(an indicator of ROS production) concentrations in the ser-
um and urine of cancer patients, this elevation correlating
with the disease stage, signiﬁcantly predicting worse progno-
sis regarding relapse and survival.
Proteins are one of the major targets of oxidative stress-
derived eﬀects on tissues. Among the diﬀerent modiﬁcations
induced by ROS in amino acid residues, that of protein car-
bonylation constitutes one of the best characterized markers
of protein oxidation in several conditions and disease states,blished by Elsevier B.V. All rights reserved.
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[20,21]. Excessive production of NO in vivo may exert
damaging eﬀects on tissues owing to its diﬀusion-limited
reaction with the superoxide anion to form peroxynitrite
[22]. This powerful oxidant species and its decomposition
products are now thought to be greatly responsible for most
of the deleterious eﬀects of excessive production of NO
[22,23]. Nitrosation and nitration reactions whereby NO is
incorporated into the target molecules are the most charac-
teristic mechanisms among the diﬀerent oxidative modiﬁca-
tions induced by peroxynitrite and other reactive nitrogen
species, RNS [23,24]. Moreover, nitration of aromatic amino
acids, lipids, and DNA bases have been shown to constitute
one of the most characteristic irreversible reactions of NO-
induced eﬀects on tissues [22,23,25]. Speciﬁcally, nitration
of the amino acid tyrosine to form 3-nitrotyrosine is now
considered to be a biomarker for the production of RNS
in vivo [22,23].
Bearing all this in mind, we hypothesized that cancer-
induced cachexia might lead to the development of increased
levels of oxidative stress in the limb muscles of rats bearing
the ascites hepatoma Yoshida AH-130. To test our hypothesis,
ﬁrstly, we aimed at assessing whether oxidative and nitrosative
stress occur in those muscles using diﬀerent indexes of protein
oxidation (protein carbonylation) and by detection of
3-nitrotyrosine immunoreactivity. Secondly, we explored mus-
cle levels of several antioxidant mechanisms that might not be
suﬃciently upregulated to counterbalance the deleterious
eﬀects of oxidative stress in those cachectic muscles.2. Materials and methods
2.1. Animals
Male Wistar rats (Interfauna, Barcelona, Spain), of about 6 weeks
of age, were used in the diﬀerent experiments (n = 6/group). The ani-
mals were maintained at 22 ± 2 C with a regular light–dark cycle
(light on from 08:00 a.m. to 08:00 p.m.) and had free access to food
and water. The diet (B.K. Universal G.J./S.L., Sant Vicenc¸ del
Horts, Barcelona, Spain) consisted of 45.5–48.5% carbohydrate
(3.5% absorbable glucose, 42–45% starch), 18.5% protein and 3.1%
fat (the residue was non-digestible material). The food intake was
measured daily. All animal manipulations were made in accordance
with the European Community guidelines for the use of laboratory
animals.2.2. Tumour inoculation
Rats were divided into two groups, namely controls and tumour
hosts. The latter received an intraperitoneal inoculum of 108 AH-130
Yoshida ascites hepatoma cells obtained from exponential tumours
[11]. On days 4 and 7 after tumour transplantation, the animals were
weighed and anesthetized with an i.p. injection of ketamine/xylazine
mixture (3:1) (Imalgene and Rompun, respectively). The tumour
was harvested from the peritoneal cavity and its volume and cellularity
evaluated. Tissues were rapidly excised, weighed, and frozen in liquid
nitrogen.2.3. Biochemicals
They were all reagent grade and obtained either from Roche (Barce-
lona, Spain) or from Sigma Chemical Co. (St. Louis, MO, USA).
2.4. Total protein carbonylation
Total levels of those highly reactive carbonyl groups in the protein
side chains were detected by reaction with 2,4-dinitrophenylhydrazine
(DNPH), resulting in the formation of 2,4-dinitrophenylhydrazone(DNP) [26]. The DNP-derivatized proteins were subsequently sepa-
rated by electrophoresis and further subjected to immunoblotting with
selective antibodies against the DNP moieties.2.5. Formation of aldehyde-protein adducts
The lipid peroxidation products malondialdehyde (MDA) and 4-hy-
droxy-2-nonenal (HNE) can cause further cellular damage by binding
to and modifying proteins leading to the formation of aldehyde-
protein adducts. The characteristic feature of these adductions are
the introduction of carbonyl groups into the modiﬁed proteins. HNE
reacts with lysine, cysteine, and histidine residues of proteins to form
Michael adducts that can be stabilized and further detected using a
selective antibody [27]. MDA reacts with lysine residues to form Schiﬀ
base adducts that can also be detected in tissues using a selective anti-
body [28].2.6. Western blot analysis
Immunoblotting was used to evaluate the eﬀects of ROS and
RNS on muscle proteins and lipids according to methodologies pre-
viously described [21]. Accordingly, total carbonyl groups, both
HNE- and MDA-protein adducts, Mn-superoxide dismutase (Mn-
SOD), catalase, and heme oxygenase-1 (HO-1) were determined on
the one hand, and protein tyrosine nitration (3-nitrotyrosine immu-
noreactivity) on the other. Frozen muscle samples (n = 6/group)
were homogenized in a buﬀer containing HEPES 50 mM, NaCl
150 mM, NaF 100 mM, Na pyrophosphate 10 mM, EDTA 5 mM,
Triton-X 0.5%, leupeptin 2 lg/ml, PMSF 100 lg/ml, aprotinin
2 lg/ml, and pepstatin A 10 lg/ml. Samples were then centrifuged
at 1000 · g for 30 min. The pellet was discarded and the supernatant
was designated as a crude homogenate. Total muscle protein level in
each sample was spectrophotometrically determined with the Brad-
ford technique using diﬀerent runs of triplicates in each case and bo-
vine serum albumin as the standard (Bio-Rad protein reagent, Bio-
Rad Inc., Hercules, CA). The ﬁnal protein concentration in each
sample was calculated from at least two almost identical Bradford
measurements. Equal amounts of total protein from crude muscle
homogenates were always loaded (20 lg per sample/lane) onto the
gels, as well as identical sample volumes/lanes. While conducting
the diﬀerent Western blot analyses, the same samples were always
run together and kept in the same order. Proteins were then sepa-
rated by electrophoresis, transferred to polyvinylidene diﬂuoride
(PVDF) membranes, blocked with non-fat milk and incubated over-
night with selective antibodies. The following antibodies were used
to detect the diﬀerent antigens and phenomena: anti-DNP moiety
antibody (Oxyblot kit, Chemicon International Inc., Temecula,
CA, USA), anti-HNE antibody (Calbiochem, San Diego, CA,
USA), anti-MDA antibody (Academy Bio-Medical Company, Inc.,
Houston, TX, USA), anti-Mn SOD antibody (StressGen, Victoria,
BC, Canada), anti-catalase antibody (Calbiochem), anti-HO-1 anti-
body (Transduction Laboratories Inc., Lexington, KY), and anti-3-
nitrotyrosine antibody (Cayman Chemical Inc., Ann Arbor, MI,
USA). Tissue homogenates obtained from rat brain mitochondria,
erythrocytes, and liver microsomes were used as positive controls
of the enzymes Mn-SOD, catalase, and HO-1, respectively. Speciﬁc
proteins from all samples were detected with horseradish peroxidase
(HRP)-conjugated secondary antibodies and a chemiluminescence
kit. For each of the antigens, samples from the three diﬀerent
groups were always detected in the same ﬁlm under identical expo-
sure times. Negative control experiments in which primary antibod-
ies were omitted or samples were not derivatized (carbonyl groups),
and membranes were then probed only with secondary antibodies
were also conducted. Blots were scanned with an imaging densitom-
eter and optical densities (OD) of speciﬁc proteins were quantiﬁed
with Diversity Database 2.1.1 (Bio-Rad, Philadelphia, PA, USA).
Values of total protein carbonylation, both total HNE- and
MDA-protein adducts, and total protein tyrosine nitration in a gi-
ven sample were calculated by addition of OD of individual protein
bands in each case. Final OD obtained in each speciﬁc group of ani-
mals (depicted in the corresponding histograms) corresponded to the
mean values of the diﬀerent samples (lanes) of each of the antigens
studied. To validate equal protein loading among various lanes,
PVDF membranes were stripped and re-probed with a monoclonal
anti-a-tubulin antibody (Sigma) in all cases. OD in each histogram
were expressed as the ratio of the OD of the speciﬁc antigen to
Table 1
Food intake, tissue weights and tumour growth in rats bearing the Yoshida AH-130 ascites hepatoma
Day 4 Day 7
Control (4) Tumour-bearing (7) Control (4) Tumour-bearing (7)
Food intake 52 ± 1 61 ± 3 123 ± 1 98 ± 1\\
Muscle weights
Gastrocnemius 590 ± 16 517 ± 9\ 651 ± 10 482 ± 23\
Tibialis 195 ± 3 173 ± 4\ 235 ± 6 161 ± 5\\
Soleus 43 ± 1 41 ± 1 51 ± 2 38 ± 1\\
EDL 46 ± 1 40 ± 1\ 53 ± 2 38 ± 1\\
Heart 402 ± 9 387 ± 17 430 ± 29 330 ± 27\
Carcass weight 101 ± 2 96 ± 2 107 ± 8 89 ± 6
Tumour cell content – 1886 ± 197 – 3596 ± 531
For more details see Section 2. Results are means ± S.E.M. for the number of animals indicated in parentheses. Food intake is expressed in g and
refers to the ingestion during the period of the experiment prior to sacriﬁce which place 4 or 7 days after tumour inoculation. Tissue weights are
expressed as mg/100 g of initial body weight. Carcass weight (body without organs or tumour) is expressed as g/100 g of initial body weight. EDL,
extensor digitorum longus. Tumour cell content is expressed in millions of cells. Statistical signiﬁcance of the results: \P < 0.05, \\P < 0.01 (control
versus tumour-bearing).
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enates on the membranes was also used to determine equal loading/
transfer across lanes.
2.7. Statistical analysis
Data are presented as means ± S.D. Mann–Whitney U (non-para-
metric test, independent samples) test was used for assessing diﬀerences
among the two groups (tumour-bearing animals and controls).3. Results
3.1. Characteristics of the study animals
Table 1 indicates the main characteristics of tumour-bearing
animals. The implantation of the Yoshida AH-130 ascites hep-
atoma resulted in a decrease in muscle weights already on day
4 after tumour transplantation (12% for gastrocnemius, 11%
for tibialis, and 13% for extensor digitorum longus), and aFig. 1. (A) Representative examples of protein oxidation (total carbonyl gro
rats sacriﬁced on days 4 and 7 (TD4 and TD7, respectively). When sampl
indicated as negative control (C). (B) OD in the histogram are expressed
(optical densities, OD; arbitrary units, a.u.). Total protein carbonylation was
control muscles (P < 0.05).much higher decrease on day 7 after tumour transplantation
(26% for gastrocnemius, 31% for tibialis, 25% for soleus,
28% for extensor digitorum longus).
3.2. Protein carbonylation
Total protein carbonylation. As shown in Fig. 1A, anti-DNP
antibody detected diﬀerent positive protein bands with appar-
ent masses ranging from 111 to 27 kDa in the gastrocnemius of
the tumour-bearing animals. In this model, the muscles of ani-
mals sacriﬁced on day 7 showed higher levels of total carbonyl
content than control muscles (Fig. 1B).
HNE- and MDA-protein adducts. Fig. 2A illustrates diﬀerent
HNE-protein adducts with apparent masses ranging from 70
to 25 kDa in the gastrocneumius of rats bearing the Yoshida
ascites hepatoma and their control animals. Total levels of
HNE-protein adducts were signiﬁcantly greater in the muscles
of rats sacriﬁced on day 7 compared to control muscles (Fig.ups) in gastrocnemius of control rats and in Yoshida tumour-bearing
es were not derivatized, no protein carbonylation could be detected,
as the ratio of the OD of total carbonyl groups to those of a-tubulin
greater in the tumour-bearing rats sacriﬁced on day 7 compared with
Fig. 2. (A) Representative examples of HNE-protein adducts in the gastrocnemius of control rats and in the Yoshida tumour-bearing animals
sacriﬁced on days 4 and 7 (TD4 and TD7, respectively). Monoclonal anti-a-tubulin antibody was used to control equal loading among various lanes.
(B) OD in the histogram are expressed as the ratio of the OD of total HNE-protein adducts to those of a-tubulin (optical densities, OD; arbitrary
units, a.u.). HNE-protein adduct formation was greater in the tumour-bearing rats sacriﬁced on day 7 compared with control muscles (P < 0.05).
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gastrocnemius of rats with apparent masses of 57, 52, and
35 kDa, respectively (Fig. 3A). As shown in Fig. 3B, total lev-
els of MDA-protein adducts were signiﬁcantly greater in the
gastrocnemius of the tumorbearing rats sacriﬁced on day 7
compared to control muscles (P < 0.05).
3.3. Antioxidant enzymes
Muscle levels of the antioxidant enzymes Mn-SOD,
catalase and HO-1 in rats bearing the Yoshida ascites hepa-
toma did not show any signiﬁcant modiﬁcation on day 4 or
on day 7 after tumour inoculation compared to controls
(Fig. 4).Fig. 3. (A) Representative examples of MDA-protein adducts in the gastro
sacriﬁced on days 4 and 7 (TD4 and TD7, respectively). Monoclonal anti-a-tu
(B) OD in the histogram are expressed as the ratio of the OD of total MDA
units, a.u.). MDA-protein adduct levels were greater in the tumour-bearing3.4. Protein tyrosine nitration
Several tyrosine-nitrated protein bands were detected in the
gastrocneumius muscles of both control and cachectic Yos-
hida-bearing rats sacriﬁced on days 4 and 7, with apparent
masses ranging from 81 to 26 kDa (Fig. 5A). Interestingly, to-
tal muscle 3-nitrotyrosine levels were greater in the gastrocne-
mius of rats sacriﬁced on day 7 (Fig. 5B).4. Discussion
The main ﬁndings of the present study are that 7 days after
the implantation of the Yoshida AH-130 ascites hepatoma incnemius of control rats and in the Yoshida tumour-bearing animals
bulin antibody was used to control equal loading among various lanes.
-protein adducts to those of a-tubulin (optical densities, OD; arbitrary
rats sacriﬁced on day 7 compared with control muscles (P < 0.05).
Fig. 5. Representative examples of protein tyrosine nitration (3-nitrotyrosine immunoreactivity) in gastrocnemius of control rats and in the Yoshida
tumour-bearing rats sacriﬁced on days 4 and 7 (TD4 and TD7, respectively). Monoclonal anti-a-tubulin antibody was used to control equal loading
among various lanes. (B) OD in the histogram are expressed as the ratio of the OD of total 3-nitrotyrosine immunoreactivity to those of a-tubulin
(optical densities, OD; arbitrary units, a.u.). Protein tyrosine nitration was greater in the tumour-bearing rats sacriﬁced on day 7 compared with
control muscles (P < 0.01).
Fig. 4. OD in the histograms are expressed as the ratio of the OD of Mn-SOD, catalase and HO-1 to those of a-tubulin, respectively (optical
densities, OD; arbitrary units, a.u.). No signiﬁcant diﬀerences were found between groups in any of the three diﬀerent antioxidant systems explored.
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creased levels of protein carbonylation as assessed by several
indexes, (b) greater 3-nitrotyrosine formation, and (c) no sig-
niﬁcant modiﬁcations in the antioxidant enzyme content com-
pared to control muscles.
4.1. Eﬀects of tumour growth on body composition
With the aim of investigating the potential role of oxidative
stress on cancer cachexia, we chose an experimental tumour
model which has a notable cachectic response. Thus, the Yos-
hida AH-130 ascites hepatoma is a rat tumour that grows
exponentially for 4–5 days and then shifts into a stationary
phase by approximately day 8 after transplantation, as previ-
ously shown [10]. Its growth causes rapid and progressive loss
of body weight and tissue waste, particularly in skeletal muscle[12]. Muscle wasting developed as early as 4 days after tumour
inocultation; however, such eﬀect was markedly evident after 7
days of cancer development.
4.2. Oxidative stress
ROS and RNS are either directly or indirectly involved in
multistage processes of carcinogenesis. They are mainly
involved in DNA damage leading sometimes to mutations in
tumour suppressor genes. Previous reports have suggested that
ROS could also have a role in muscle wasting. Speciﬁcally,
Buck and Chojkier [17] showed that the cytokine TNF played
a central role in mediating the release of both ROS and RNS,
ﬁnding which is in agreement with other previous reports [6].
Furthermore, those investigators also showed that MDA-pro-
tein adducts were markedly increased in the muscles of the
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tration of the antioxidant D-a-tocopherol clearly abrogated
such an increase, and prevented the muscle wasting of those
animals [17]. Other authors have also reported an increase in
MDA in the blood of advanced gastric cancer patients [29]
as well as high levels of this type of aldehyde in skeletal muscle
during cancer cachexia [18].
Given the fact that the DNPH assay indiscriminately detects
total protein carbonyl groups formed by diverse species such
as hydroxyl and alkylperoxyl radicals, MDA, and HNE [30],
and that lipid peroxidation is a common phenomenon of oxi-
dative stress [31,32], we decided to speciﬁcally detect whether
both MDA- and HNE-protein adducts were increased in the
cachectic muscles of our tumour-bearing rats. Indeed, both
MDA- and HNE-protein adducts were found to be greater
in the gastrocnemius of these animals compared with controls,
suggesting that peroxidation of polyunsaturated membrane
lipids is likely to be a continuing event during the muscle wast-
ing process.
Total mucle protein carbonylation levels, as measured by
the DNPH assay, were also increased in the cachectic gas-
trocnemius muscles. Based on this, we can speculate that,
in our experimental model of cancer cachexia, active oxida-
tive cellular damage must occur (probably via TNF) during
the process of muscle wasting. Actually, soon after TNF
exposure, ROS can alter contractile regulation reducing mus-
cle force, while late eﬀects of that cytokine on tissues lead to
ROS-mediated upregulation of the ubiquitin/proteasome
pathway (through NF-jb activation) accelerating protein
degradation and muscle mass loss [33]. Indeed, it is thought
that the importance of oxidative stress as a contributing fac-
tor to cancer-induced cachexia is based on the increased sus-
ceptibility of oxidized proteins to undergo proteolytic
degradation [34,35].
Another important aspect considered in the present study
was the assessment of whether reduced food intake in the
cachectic animals might have any eﬀect on the levels of muscle
protein carbonylation. Since hypophagia is present in Yoshida
AH-130 tumour bearers on day 7, experiments using pair-fed
rats were used, and no signiﬁcant diﬀerences in those levels
were detected with respect to control muscles (results not
shown). Eventually, it is also worth considering that minimum
levels of ROS were present in control muscles as shown by
those oxidized protein bands of similar sizes to the ones ob-
served in cachectic muscles (Figs. 1–3). This is actually consis-
tent with the fact that relatively low levels of ROS are required
for normal force production [36].
Muscle content of the three diﬀerent antioxidant systems
analyzed in the current study were not signiﬁcantly modiﬁed
in the advanced cachexia state with respect to control mus-
cles, albeit protein levels of both Mn-SOD and catalase
tended to increase in the cachectic gastrocnemius. Therefore,
we can conclude from our data that these three diﬀerent
antioxidant mechanisms do not seem to have major protec-
tive eﬀects against oxidative stress in this model of cancer-
induced cachexia. One could speculate from these ﬁndings
that cancer conditions might alter either the content or the
activity of those enzymes, or even modify their regulatory
mechanisms responsible for clearly upregulating their levels.
For instance, MacMillan-Crow et al. [37–39] have already
shown in diﬀerent studies that peroxynitrite leads to nitra-
tion and inactivation of Mn-SOD in vivo under several con-ditions including human pancreatic ductal adenocarcinoma.
In our study, the absence of a signiﬁcant increase in the con-
tent of these antioxidant mechanisms along with the ex-
pected lack of increased Mn-SOD activity would certainly
lead to greater levels of muscle oxidative stress in the
cachectic animals.
4.3. Reactive nitrogen species
Buck and Chojkier [17] showed in their study that treatment
of cachectic mice with nitro-L-arginine, a NO synthase inhibi-
tor, prevented weight loss as well as the deleterious eﬀects of
TNF on muscle. On the grounds that excessive NO production
could be one contributing mechanism to cancer-induced ca-
chexia, we explored whether 3-nitrotyrosine formation was in-
creased in cachectic muscles. In eﬀect, protein tyrosine
nitration was markedly greater in the muscles of tumour-bear-
ing rats with advanced cachexia (day 7). These ﬁndings led us
to the conclusion that muscle wasting, at least under experi-
mental cancer conditions, is strongly associated with nitrosa-
tive stress. This is specially important since nitration of
tyrosine residues has been shown to trigger an increased degra-
dation by the proteasome of the modiﬁed proteins [40]. Even-
tually, we also conclude that cachexia per se was associated
with the development of nitrosative stress in the cancer-in-
duced cachectic muscles since hypophagia (pair-fed animals)
did not show any signiﬁcant increase in protein tyrosine nitra-
tion (data not shown).
4.4. Concluding remarks
In conclusion, in this study we provide ﬁrst evidence of the
existence of a clear association between experimental cancer-
induced cachexia and the development of both oxidative and
nitrosative stress. The levels of three major antioxidant mech-
anisms were also explored, showing no signiﬁcant increase
within the cachectic muscle ﬁbers. This indicates that altera-
tions in those antioxidant systems might contribute to worsen
the levels of both oxidative stress and muscle wasting. This
hypothesis requires further investigation, since some antioxi-
dant proteins can be pharmacologically induced, suggesting a
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